Skip to main content

Table 2 Enrolled patients’ characteristics

From: Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer

Characteristic No of patients
(N = 21)
%
Age (years)  
 Median 67
 Range 43–75
Sex   
 Male 8 38
 Female 13 62
ECOG performance status   
 0 21 100
 1 0 0
CA 19–9 at diagnosis, U/mL  
 Median 1028,15
 Range 0–6688
Tumor localization   
 Head 21 100
 Body/Tail 0 0
Resectability status   
 Borderline resectable 3 14
 Unresectable 18 86